Comparison of Esophageal Dose Parameters in Breast Cancer Radiotherapy With and Without Esophageal Contouring.

Authors

Rajhans Kumar, Pritanjali Singh, Rohit Saini, Jahnavi Kodela

Published in

Cureus. Volume 18. Issue 8. Pages e113888. Epub Aug 03, 2026.

Abstract

Context This study investigates the effect of esophageal delineation on dose-volume parameters during breast cancer radiotherapy (RT), aiming to optimize treatment planning and reduce the risk of acute esophageal toxicity. Methods A retrospective study was conducted on radiotherapy plans from 100 patients with breast cancer (mean age: 45 years) who received three-dimensional conformal radiotherapy (3DCRT) targeting the chest wall and supraclavicular fossa (SCF). All patients were treated with a hypofractionated schedule of 40 Gy in 15 fractions. Initially, esophageal contouring was excluded. In a secondary phase, the esophagus was delineated as an organ at risk (OAR), and the plans were revised accordingly. Dosimetric comparisons included maximum (D_max), minimum (D_min), and mean (D_mean) esophageal doses, along with the volume of the esophagus receiving doses ≥5 Gy (V5), ≥10 Gy (V10), ≥15 Gy (V15), ≥20 Gy (V20), ≥25 Gy (V25), and ≥33 Gy (V33). Additionally, ipsilateral lung volumes (V4, V8, and V16), the Homogeneity Index (HI), and Conformity Index (CI) were assessed to evaluate plan quality. Results Delineating the esophagus significantly reduced the radiation dose it received (p < 0.05), without affecting planning target volume (PTV) coverage or compromising plan quality, as indicated by consistent HI and CI values; lung dose parameters remained largely unchanged, although higher mean esophageal doses were observed in left-sided breast cancer cases due to the esophagus's closer proximity to the supraclavicular fossa, which made beam modulation more challenging. Conclusions Incorporating esophageal delineation in 3DCRT planning for breast cancer significantly reduces esophageal dose exposure without compromising dosimetric quality. This adjustment may contribute to minimizing acute esophageal toxicity and enhancing treatment safety.

PMID:
42689276
Bibliographic data and abstract were imported from PubMed on 03 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.